22 Aug 2025 12:32 CEST

Issuer

FACEPHI BIOMETRIA S.A

During the Extraordinary General Shareholders’ Meeting of FACEPHI BIOMETRÍA, S.A. (hereinafter, “FACEPHI” or the “Company”), held on August 21, 2025, on second call and with the attendance of a total of 10 shareholders, present or duly represented, representing 34.78% of the Company’s share capital, the resolution submitted to a vote in accordance with the notice of the General Meeting published at the time was approved.

The resolution adopted is as follows and was approved by an absolute majority:

FIRST – Authorization to the Board of Directors so that any of its members may, within the framework of the Tax Lease transaction agreed with Leyton, grant as many public and/or private documents as it deems convenient or necessary for the subscription, formalization, elevation to public, modification, novation, recasting, ratification, execution, correction, amendment, supplementation, clarification and/or cancellation of the Documents of said transaction, including, in particular but without limitation, the granting of an irrevocable power of attorney in favour of LEYTON IMPULSE, S. L.U. in connection with the Framework Agreement and the Put Option Agreement, so that it may execute, among other ancillary documents, the deed of sale of the EIG's participation quotas in the name and on behalf of Facephi Biometría, S.A., even in the event of self-contracting, double representation, multiple representation, conflict of interest or delegation.

The granting of the said authorization was approved following the vote, with 4,000 votes against, 9,200 abstentions, and 9,274,435 votes in favor.

ago-21-25-acuerdos-agm-euronext.pdf

Source

FACEPHI

Provider

Euronext

Company Name

FACEPHI

ISIN

ES0105029005

Symbol

ALPHI

Market

Euronext Growth